Urine-derived stem cell extracellular vesicles promote recovery from acute kidney injury in mice and human kidney organoids

Authors:

Abstract
Urine-derived stem cell extracellular vesicles (USC-EVs) increased proliferation while lowering apoptosis and lipid peroxidation in human kidney cells and organoids treated with toxic chemotherapy. In the acute kidney injury (AKI) model mice, we found lowered inflammation, tubular dilation, casts, and kidney injury marker neutrophil gelatinase-associated lipocalin (NGAL) with USC-EV treatment. The USC-EVs carry microRNA cargo that bioinformatic tools predict will affect multiple pathways, including the MAPK cascade. Altogether, our results suggest that USC-EVs may improve recovery from AKI.
Funding Information
  • U.S. Department of Veterans Affairs (BX004845)
  • U.S. Department of Veterans Affairs (BX006554)
  • National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK114809-02)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK020593)
  • Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center (UL1 TR002243)
  • American Diabetes Association (11-23-PDF-30)
  • Pharmaceuticals Bayer
  • National Cancer Institute (CA68485)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK58404)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK59637)
  • National Eye Institute (EY08126)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK141801)
  • National Heart, Lung, and Blood Institute (HL147818)

This publication has 79 references indexed in Scilit: